|
|
.
See Category: Diseases of the nervous system
See Header: Local-rel (focal) symptc epi w complex partial seiz, ntrct
ICD-10 (CM) Code and Descriptor
|
G40.219 |
Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus
|
G40219 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 66.45%
|
15.58%
|
6.50%
|
3.72%
|
2.61%
|
1.70%
|
1.13%
|
0.72%
|
0.46%
|
0.36%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G40.219*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
6,340
|
6,350
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
4,241
|
4,259
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,763
|
2,763
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,444
|
2,445
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
1,693
|
1,696
|
|
80175
|
DRUG SCREEN QUAN LAMOTRIGINE |
1,440
|
1,440
|
|
80177
|
DRUG SCRN QUAN LEVETIRACETAM |
1,270
|
1,270
|
|
97530
|
THERAPEUTIC ACTIVITIES |
1,014
|
1,810
|
|
80164
|
ASSAY DIPROPYLACETIC ACD TOT |
951
|
959
|
|
97110
|
THERAPEUTIC EXERCISES |
817
|
1,296
|
|
85027
|
COMPLETE CBC AUTOMATED |
718
|
719
|
|
80156
|
ASSAY CARBAMAZEPINE TOTAL |
700
|
704
|
|
80185
|
ASSAY OF PHENYTOIN TOTAL |
624
|
630
|
|
95970
|
ALYS NPGT W/O PRGRMG |
594
|
594
|
|
80048
|
METABOLIC PANEL TOTAL CA |
573
|
575
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
551
|
1,626
|
|
82306
|
VITAMIN D 25 HYDROXY |
530
|
530
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
443
|
12,166
|
|
80235
|
DRUG ASSAY LACOSAMIDE |
442
|
442
|
|
80183
|
DRUG SCRN QUANT OXCARBAZEPIN |
423
|
423
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G40.219 related to the following DRG Codes:
023
100-101
|
